Phenotypic Characterization of Leucine-rich Repeat Kinase 2 (LRRK2) Knockout Rat Model: A Multi Parameter Cross Platform Biomarker Study

biomarker-an-abstract-depiction-of-molecular-diagnostics-featuring-illustrations-of-biomarkers-adobestock_837852163

A multi-platform approach can provide deeper insights into neurodegenerative disease biology.

Identifying meaningful biomarkers for neurodegenerative diseases requires integrating data from multiple analytical technologies. This poster highlights a cross-platform biomarker study using an LRRK2 knockout rat model to investigate early biological changes associated with Parkinson's disease and evaluate potential biomarkers for translational research.

Key highlights include:

  • Cross-platform biomarker analysis using an LRRK2 knockout rat model
  • Integration of histology, flow cytometry, gene expression, and multiplex biomarker analysis
  • Characterization of biological changes associated with Parkinson's disease
  • Identification of potential biomarkers to support translational research
  • Insights into multi-platform approaches for neurodegenerative disease studies

As biomarker strategies continue to evolve, combining complementary analytical technologies can provide a more comprehensive understanding of disease biology. See how an integrated, multi-platform approach can support biomarker discovery and advance neurodegenerative disease research.

Complete the form below to access this poster.

Phenotypic Characterization of Leucine-rich Repeat Kinase 2 (LRRK2) Knockout Rat Model: A Multi Parameter Cross Platform Biomarker Study

To learn more about how Eurofins processes and protects your personal data and your rights, please read our Privacy Notice.